Journal profile · Pathology
Journal of Molecular Diagnostics
ISSN 1525-1578 · eISSN 1943-7811 · Elsevier Inc. · UNITED STATES · Bimonthly · Founded 1999
Journal of Molecular Diagnostics: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.85; hybrid open access; APC about USD 3,000; median 155 days to acceptance (101 articles, last 24 months); community-reported acceptance: moderate; 152 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Molecular Diagnostics is published by Elsevier Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications and Diverse Scientific and Economic Studies, together about 32.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Molecular Diagnostics Official journal of the Association for Molecular Pathology (AMP) Opens in new window The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP) Opens in new window , co-owned by the American Society for Investigative Pathology (ASIP) Opens in new window , seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. More Society Information
From the journal's Aims & Scope
Research area (LetPub): Pathology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology16.1%
- Molecular Biology Techniques and ApplicationsBiochemistry, Genetics and Molecular Biology8.5%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance7.9%
- Genomics and Rare DiseasesBiochemistry, Genetics and Molecular Biology5.8%
- Genetic factors in colorectal cancerMedicine5.4%
- Genomic variations and chromosomal abnormalitiesBiochemistry, Genetics and Molecular Biology4.5%
- Human auditory perception and evaluationEngineering4.4%
- Educational Robotics and EngineeringComputer Science4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.85LetPub ·
- Impact factor (publisher)
- 3.9Publisher website ·
- CiteScore 2026-06
- 6.3LetPub ·
- CiteScore (publisher)
- 6.3Publisher website ·
- SJR 2026-06
- 1.42LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 85LetPub ·
- h-index
- 132OpenAlex ·
- i10-index
- 1,632OpenAlex ·
- 2-year mean citedness
- 3.04OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 30.88%LetPub ·
Volume
- Articles per year
- 105LetPub ·
Articles by year OpenAlex count · 2,819 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 86 | 37 | 23 |
| 2025 | 152 | 113 | 306 |
| 2024 | 140 | 139 | 820 |
| 2023 | 131 | 131 | 1,117 |
| 2022 | 144 | 144 | 1,908 |
| 2021 | 180 | 176 | 2,843 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
155 daysMedian, submission to acceptance · P25–P75 98 days – 211 days
- Acceptance to online
- median 22 days (95 articles)
- Submission to online
- median 176 days
- Sample
- 101 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Acceptance to publication
- 30 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,000 / EUR 2,810 / GBP 2,400 / JPY 372,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1999
- ISSN
- 1525-1578
- Electronic ISSN
- 1943-7811
- Society / sponsor
- Association for Molecular Pathology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Molecular Diagnostics
What CAS zone is Journal of Molecular Diagnostics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Molecular Diagnostics is in Zone 3 of Medicine, and in Zone 2 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Molecular Diagnostics?
The latest impact factor listed by LetPub is 3.85; CiteScore 6.3, h-index 132.
How long does peer review take at Journal of Molecular Diagnostics?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 155 days (interquartile range 98–211 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Molecular Diagnostics?
According to LetPub and DOAJ records, Journal of Molecular Diagnostics is indexed in SCIE and Scopus.
Is Journal of Molecular Diagnostics open access, and what is the APC?
Journal of Molecular Diagnostics is a hybrid journal. For open-access publication: APC about USD 3,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .